Articles From: Finjan Holdings Reports $5 Million In Q3 Licensing Revenue to GOL Announces Its 3Q14 Results

License agreement provides for a payment of $8M, of which $5M recorded in Q3 $0.02 per share in net income NEW YORK , Nov.
Sign-up for Finjan Holdings Reports $5 Million In Q3 Licensing Revenue investment picks
Sign-up for First Industrial Realty Trust Declares Common Stock Dividends investment picks
Today the FIRST ® in Texas Foundation , a nonprofit dedicated to funding, training and supporting FIRST ® Robotics programs across the state of Texas, announced it will be the sole beneficiary of funds raised by the Freescale Foundation during the 2015 Austin Marathon and Half Marathon , presented by Freescale.
Sign-up for FIRST® in Texas Announced as Beneficiary of Freescale Foundation Fundraising Efforts at 2015 Austin Marathon investment picks
Sign-up for Flowonix Completes $40 Million Financing investment picks
ForeverGreen continues to experience triple digit year-over-year growth PLEASANT GROVE, Utah , Nov.
Sign-up for ForeverGreen Worldwide Corporation's October 2014 Sales Increase 130% investment picks
Third Quarter Net Sales Increase 10% to $894 Million; Diluted EPS Increases 24% to $1.96 RICHARDSON, Texas, Nov.
Sign-up for Fossil Group, Inc. Reports Third Quarter 2014 Results investment picks
Fossil Group Inc. shares (FOSL) jumped 11% in after-hours trading after the watch and accessories maker reported better-than-expected third-quarter profit and sales.
Sign-up for Fossil shares jump after Kors license renewal, third-quarter profit beats investment picks
Veterans on Wall Street (VOWS), a consortium of major financial institutions including Citi, Deutsche Bank and Goldman Sachs, held their fourth annual Veteran Employment Symposium and Resource Fair on November 5 th in New York City.
Sign-up for Fourth Annual Veterans on Wall Street Symposium and Resource Fair Attracts Record Number of Military Veterans and Service Members investment picks
As a founding member of Thread Group, an industry alliance focused on creating a simple, secure and low-power network for the connected home, Freescale Semiconductor (NYSE: FSL) announced today its Thread beta development program.
Sign-up for Freescale Establishes Thread Beta Development Program to Help Companies Jump-Start Next-Generation IoT Products investment picks
Freescale Semiconductor (NYSE: FSL) today announced the expansion of its system power management portfolio to support key members of its industry-leading embedded networking products.
Sign-up for Freescale Expands System Power Management Portfolio to Its QorIQ LS1 Processors for a Secure Internet of Things investment picks
Frontier Communications Corporation (NASDAQ: FTR) is scheduled to participate in the Wells Fargo Tech, Media & Telecom Conference on Thursday, November 13, 2014.
Sign-up for Frontier Communications Corporation to Participate in Investor Conference investment picks
In many communities served by Frontier Communications Corporation (NASDAQ:FTR) in 28 states, Veterans Day culminates a series of activities in appreciation of those who sacrifice for our country.
Sign-up for Frontier Communications Reaffirms Commitment to Military Veterans investment picks
Sign-up for FTD Companies, Inc. to Present at Upcoming Investor Events investment picks
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- The U.K.'s FTSE 100 index climbed for a fifth straight day on Tuesday, led by Vodafone Group PLC that advanced after a well-received earnings report.
Sign-up for FTSE 100 higher for fifth day with Vodafone on top investment picks
-Teleconference to be held on Friday, November 21, 2014 at 8:00 am EST- BEIJING , Nov.
Sign-up for Fuwei Films to Report Its Unaudited Financial Results for the Third Quarter of 2014 onThursday, November 20, 2014 investment picks
Trial expands the eligible patient population and overall NeuVax clinical trial portfolio Recent patent allowance provides intellectual property protection for NeuVax in combination with Herceptin in any HER2/neu expressing cancer PORTLAND, Ore., Nov.
Sign-up for Galena Biopharma Doses First Patient in Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in Combination With Herceptin(R) (trastuzumab) to Treat High-Risk HER2 3+ or HER2 Gene-Amplified Breast Cancer Patients investment picks
GE Healthcare and Takeda Pharmaceutical Company announced that they have entered into an alliance agreement for research and development in the field of hepatic fibrosis, a key factor in the diagnosis and treatment of liver diseases.
Sign-up for GE Healthcare and Takeda Join Forces to Develop Therapeutic Drugs to Target Liver Diseases investment picks CALGARY, ALBERTA --
Sign-up for Gear Energy Ltd. Announces 2015 Capital Budget investment picks CALGARY, ALBERTA --
Sign-up for Gear Energy Ltd. Announces Record Third Quarter 2014 Results investment picks
Ceremony signals the start of construction for SEA-Vista ECO Tanker, the first of three tanker ships to be constructed locally at NASSCO SAN DIEGO , Nov.
Sign-up for General Dynamics NASSCO Celebrates Start of Construction for Three SEA-Vista Commercial Product Tankers investment picks
Youth & Family Service Projects Take Spotlight with Campaigns Sponsored by Hasbro, Inc. and Disney Friends for Change NEW YORK , Nov.
Sign-up for generationOn Seeks to Ignite the Power of Giving Back in Kids, Teens, Families and Schools Nationwide investment picks
Genesee & Wyoming Inc. (G&W) (NYSE:GWR) today reported traffic volumes for October 2014.
Sign-up for Genesee & Wyoming Reports Traffic for October 2014 investment picks
Before the holiday shopping season kicks into high gear, Sprint (NYSE: S) will offer Nexus 6 with 2.5GHz LTE data speeds and a pure Android™ experience coupled with rate plans like the Sprint Family Share Pack offering the best value for families who want shared data.
Sign-up for Get Nexus 6 on Nov. 14 with the Sprint Family Share Pack - The Best Value for Families Who Want Shared Data investment picks
Reports EPS of ($0.01) Ended the third quarter with cash and cash equivalents of $14.0 million Isobutanol production rates accelerate following the commissioning of the final phase of capital equipment for Side-by-Side operational mode Total supplying Formula 1 ® racing fuel containing Gevo's renewable isooctane Gulf Racing Fuels selling high performance fuels using Gevo's renewable isobutanol ENGLEWOOD, Colo., Nov.
Sign-up for Gevo Reports Third Quarter 2014 Financial Results investment picks
Gilead Sciences, Inc. (Nasdaq:GILD) today announced data from three Phase 2 open-label studies evaluating the safety and efficacy of an investigational all-oral pan-genotypic regimen containing the nucleotide analog polymerase inhibitor sofosbuvir (SOF), approved as Sovaldi ® by the U.S. Food and Drug Administration in December 2013, and the investigational NS5A inhibitor GS-5816 for the treatment of chronic hepatitis C virus (HCV) infection.
Sign-up for Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C investment picks LONDON, UNITED KINGDOM --
Sign-up for Global Biopharmaceutical Company UCB Expands Real Estate Services Relationship With JLL investment picks
GNCC Capital, Inc. (OTC:GNCP) (“The Company”) announced on September 29, 2014 and confirmed on October 30, 2014, that its Board of Directors intended to recommend re-domiciling the Company from Delaware to Wyoming.
Sign-up for GNCC Capital, Inc. Confirms Re-Domiciling to Effect Stock Buyback Program investment picks
GOL records operating income of R$ 152 million with 6.2% operating margin in the 3Q14, a 4.5 percentage point improvement YoY SAO PAULO , Nov.
Sign-up for GOL Announces Its 3Q14 Results investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.


Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Finjan Holdings Reports $5 Million In Q3 Licensing Revenue to GOL Announces Its 3Q14 Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent